Literature DB >> 10998425

The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression.

N L Urizar1, D H Dowhan, D D Moore.   

Abstract

Bile acids facilitate the absorption of dietary lipids and fat-soluble vitamins and are physiological ligands for the farnesoid X-activated receptor (FXR), a member of the nuclear hormone receptor superfamily. FXR functions as a heterodimer with the retinoid X receptor and in the presence of ligand, the heterodimer binds to specific DNA sequences in the promoters of target genes to regulate gene transcription. Phospholipid transfer protein (PLTP) has been identified as a possible target gene for FXR because the human promoter contains a potential FXR response element, an inverted repeat in which consensus receptor-binding hexamers are separated by one nucleotide (inverted repeat-1). PLTP is essential in the transfer of very low density lipoprotein phospholipids into high density lipoprotein (Jiang, X. C., Bruce, C., Mar, J., Lin, M., Ji, Y., Francone, O. L., and Tall, A. R. (1999) J. Clin. Invest. 103, 907-914). Here we report the regulation of PLTP gene expression by FXR and bile acids. In CV-1 cells, cotransfection of FXR and the retinoid X receptor resulted in bile acid-dependent transactivation of a luciferase reporter construct containing the human PLTP promoter. Mutation analysis demonstrated that the inverted repeat-1 (IR-1) in the PLTP promoter is required for this transactivation. Finally, we demonstrate that bile acids are able to regulate PLTP gene expression in vivo. Mice fed a chow diet supplemented with bile acid showed increased hepatic PLTP mRNA levels. These results suggest that FXR may play a role in high density lipoprotein metabolism via the regulation of PLTP gene expression.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10998425     DOI: 10.1074/jbc.M007998200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

Review 1.  Role of bile acids in the regulation of the metabolic pathways.

Authors:  Hiroki Taoka; Yoko Yokoyama; Kohkichi Morimoto; Naho Kitamura; Tatsuya Tanigaki; Yoko Takashina; Kazuo Tsubota; Mitsuhiro Watanabe
Journal:  World J Diabetes       Date:  2016-07-10

2.  Effects of FXR in foam-cell formation and atherosclerosis development.

Authors:  Grace L Guo; Silvia Santamarina-Fojo; Taro E Akiyama; Marcelo J A Amar; Beverly J Paigen; Bryan Brewer; Frank J Gonzalez
Journal:  Biochim Biophys Acta       Date:  2006-10-14

3.  Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner.

Authors:  Josep Maria Del Bas; Marie-Louise Ricketts; Montserrat Vaqué; Esther Sala; Helena Quesada; Anna Ardevol; M Josepa Salvadó; Mayte Blay; Lluís Arola; David D Moore; Gerard Pujadas; Juan Fernandez-Larrea; Cinta Bladé
Journal:  Mol Nutr Food Res       Date:  2009-07       Impact factor: 5.914

4.  Activation of the nuclear receptor FXR improves hyperglycemia and hyperlipidemia in diabetic mice.

Authors:  Yanqiao Zhang; Florence Ying Lee; Gabriel Barrera; Hans Lee; Charisse Vales; Frank J Gonzalez; Timothy M Willson; Peter A Edwards
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-12       Impact factor: 11.205

5.  Genetic and nongenetic sources of variation in phospholipid transfer protein activity.

Authors:  Gail P Jarvik; Ramakrishnan Rajagopalan; Elisabeth A Rosenthal; Gertrud Wolfbauer; Laura McKinstry; Aditya Vaze; John Brunzell; Arno G Motulsky; Deborah A Nickerson; Patrick J Heagerty; Ellen M Wijsman; John J Albers
Journal:  J Lipid Res       Date:  2009-11-02       Impact factor: 5.922

Review 6.  Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration.

Authors:  Bart Staels; Vivian A Fonseca
Journal:  Diabetes Care       Date:  2009-11       Impact factor: 19.112

7.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Li Wang; Antonio Moschetta; David J Mangelsdorf; Richard A Heyman; David D Moore; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

8.  Ligand-binding domain of farnesoid X receptor (FXR) had the highest sensitivity and activity among FXR variants in a fluorescence-based assay.

Authors:  Kyung-Hyun Cho; Ji-Young Park; Jang-Il Han; Tae-Sook Jeong
Journal:  Lipids       Date:  2003-11       Impact factor: 1.880

9.  Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR.

Authors:  Yanqiao Zhang; Lawrence W Castellani; Christopher J Sinal; Frank J Gonzalez; Peter A Edwards
Journal:  Genes Dev       Date:  2004-01-16       Impact factor: 11.361

Review 10.  Xenobiotic-sensing nuclear receptors involved in drug metabolism: a structural perspective.

Authors:  Bret D Wallace; Matthew R Redinbo
Journal:  Drug Metab Rev       Date:  2012-12-05       Impact factor: 4.518

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.